Tuesday, April 21 2026

Ethics training mandatory for Atlanta realtors

firststargroup June 25, 2018

Construction company picked for beachfront condo project

firststargroup June 9, 2022

F.W. Webb searching for new location for $14 million expansion

firststargroup September 5, 2023

CACI’s defense of executive pay practices wins over proxy advisory firm ISS

firststargroup October 17, 2023

Large commercial real estate firm hires senior managing director for Triad and Triangle offices

firststargroup April 11, 2018

Amazon, Fred Hutch collaborating on cancer vaccine clinical trial

firststargroup July 13, 2022

Twin Cities homebuilding hits lowest point in past 12 months

firststargroup September 3, 2022

Crestlight Capital seeks rezoning to add apartments and retail at SouthPark Towers

firststargroup August 2, 2022

Eisai shuts down Cambridge-based subsidiary

firststargroup July 19, 2022

H3 Biomedicine Inc., a Cambridge-based cancer biotech owned by Japanese pharmaceutical company Eisai, is shutting down.

About the author

firststargroup

Suggested Posts

Top 150+ 2018: No. 28 Fabick CAT

CFO Lifetime Achievment: Kerwin has blended mission with the balance sheet

Oversized bayfront Avalon property with 1,000-SF rooftop deck, guest house lists for $8M

French-inspired Cocody Restaurant and Bar opens in River Oaks Shopping Center

Old Daley buys New World Bistro Bar building in Albany

Portland app maker acquired by out-of-state insurer

More Stories

KCI begins placing orders for food, concessions providers

firststargroup July 10, 2019